Pharma’s Cutting Edge

Pharma’s Cutting Edge

Pharmaceutical and biotech science and business

 
 
 
 

OSI closes merger with Eyetech

Since I’ve been spouting off vociferously on this deal, I just wanted to provide some closure, in case you missed the story yesterday. OSI did indeed go through with the merger as planned. I will follow-up on the progress of Macugen, Tarceva and the rest of OSI in 6 months to a year from now, unless readers have a specific issue you would like me to address before then.

Leave a Reply

You must be logged in to post a comment.

Pages

Recent Posts

Pharma's Cutting Edge Archives

Categories

Meta

Blogroll

Syndicate

  • Subscribe to my feed